We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.
- Authors
Campone, M; Bondarenko, I; Brincat, S; Hotko, Y; Munster, P N; Chmielowska, E; Fumoleau, P; Ward, R; Bardy-Bouxin, N; Leip, E; Turnbull, K; Zacharchuk, C; Epstein, R J
- Abstract
This phase II study evaluated single-agent bosutinib in pretreated patients with locally advanced or metastatic breast cancer.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 3, p610
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdr261